Theralase Technologies Inc. V.TLT

COVID-19 vaccine

[ScienceFirst]

A new type of Covid-19 vaccine just released its results.  Cutting hospitalization in half among already vaccinated patients and successful no matter the variant

The stock is up +69% @89M$US market valuation in the after-hours on the NASDAQ.  In 2020-2021, it was valued between 300-400M$US.

Let's track where the valuation of this stock will go over time as it could be indicative of what our vaccine could possibly be valued, in due time.

 

Trial Of New Covid Treatment Yields Encouraging Results: Study

A single-injection antiviral treatment for newly-infected Covid-19 patients reduced the risk of hospitalization by half in a large-scale clinical trial, according to a study published on Wednesday.

Stanford University professor Jeffrey Glenn, coauthor of the study published in the New England Journal of Medicine (NEJM), said the new drug "showed profound benefits for vaccinated and unvaccinated people alike."

While the number of Americans dying daily of coronavirus has fallen to around 500, treatments for the disease remain limited. One of the most common, Paxlovid made by Pfizer, involves taking 30 pills over five days.

The new treatment involves a single dose of pegylated lambda-interferon, a synthetic version of a naturally occurring protein that infected cells secrete to defend against viral infection.

"What it does is it binds receptors on the surfaces of cells that activate our own antiviral defense mechanisms," said Glenn, a professor of medicine, microbiology and immunology who heads the Stanford Biosecurity and Pandemic Preparedness Initiative.

https://www.barrons.com/amp/news/trial-of-new-covid-treatment-yields-encouraging-results-study-01675893908

https://www.nejm.org/doi/full/10.1056/NEJMoa2209760?query=featured_home

https://www.cnbc.com/quotes/EIGR

[marlinbait]

This post has been removed in accordance with Community Policy

[ScienceFirst]

Ouf!!! First, the study I posted is a different technology.  And was proven in a gold standard study. Second, according to your statement then, even TLT's COVID-19 vaccine wouldn't work! Wow! It's rather case by case.  Supported by clinical data.  

[gojotv!]

You can always count on the illiterate readership of the "Epoch Times" to make statements unsupported by the studies they are quoting... This "Tyler" fool says, "...the vaccine didn't work because it could not work"... ...while the article clearly states, "During the COVID-19 pandemic, the rapid development and deployment of SARS-CoV-2 vaccines has saved

[RetiredREX]

Sounds more like a treatment for people infected with COVID.   They compare reduction in severe illness for vaccinated people who took the one time injection after infection with those who took placebo.  Also indicated is an even greater effectiveness for those infected but unvaccinated... A Canadian-led study of a new potential antiviral therapy shows a single dose can help cut